GENESYS
Genesys International Corporation Ltd
Each stock's 10,000-path forecast, rendered as light.
Genesys International Corporation Ltd (GENESYS) Stock Analysis & Case Study
Is GENESYS a good buy? The data-driven verdict.
Genesys International Corporation Ltd (GENESYS) trades at ₹227,on the numbers it high-risk on the numbers, a Downstox Snapshot Score of 22/100.
On the numbers, Genesys International Corporation Ltd (GENESYS) high-risk on the numbers, a Downstox Snapshot Score of 22/100, weighing expensive at 42.1× earnings, ROE of 5.7%, a 44% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
GENESYS fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How GENESYS ranks against the 2,373 companies in our screener
- GENESYS's market cap of 1,521 Cr ranks in the 46th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- GENESYS's book value of ₹105 ranks in the 53rd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- GENESYS's promoter holding of 31.5% ranks in the 9th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- GENESYS's 3-year profit (PAT) growth of 26.0% ranks in the 65th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- GENESYS's 3-year revenue growth of 22.0% ranks in the 76th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- GENESYS's debt-to-equity ratio of 0.25x is lower than 57% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is GENESYS overvalued? GENESYS P/E vs peers
GENESYS trades at 42.1× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
GENESYS share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 9.8y of GENESYS history (13%/yr drift, 66%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| GENESYS 2027 | ₹89 | ₹207 | ₹481 | -9% |
| GENESYS 2028 | ₹56 | ₹188 | ₹633 | -17% |
| GENESYS 2029 | ₹38 | ₹170 | ₹772 | -25% |
| GENESYS 2030 | ₹28 | ₹155 | ₹866 | -32% |
| GENESYS 2031 | ₹20 | ₹141 | ₹992 | -38% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability GENESYS goes up, or doubles?
The bull case for GENESYS
- Genesys International Corporation Ltd is part of the nifty500 universe with live, tracked fundamentals on Downstox.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹772.
The bear case & risks
- GENESYS's P/E of 42.1x is lower than 32% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- GENESYS's return on equity of 5.7% ranks in the 32nd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- The probability model is cautious 12 months out, only a 44% chance of finishing above today's price.
- High historical volatility (66%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹38.
GENESYS volatility & expected range, how bumpy is the ride?
Over the last 9.8 years GENESYS compounded at 13%/year with annualized volatility of 66%. That volatility implies a 1-year 80% range of ₹89-₹481, the honest backbone behind any single price target.
GENESYS price forecast, the full 60-month probability fan
GENESYS price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds GENESYS hits common targets within the simulated horizon?
Full multi-horizon detail on the GENESYS price target & forecast page.
GENESYS Piotroski F-Score: 5/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. GENESYS scores 5/8, mixed financial health.
GENESYS MTF margin & leverage across 7 brokers
Margin Trading Facility lets you buy GENESYS with part of the capital. Lower margin % = higher leverage. Rates compared across 7 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 45.97% | 2.2× |
| Groww | 46.05% | 2.2× |
| Dhan | 45.89% | 2.2× |
| Kotak NeoCHEAPEST | 45.87% | 2.2× |
| Paytm Money | 70.00% | 1.4× |
| Anand Rathi | 45.89% | 2.2× |
| Share India | 45.97% | 2.2× |
Compare every broker on the GENESYS MTF page.
About Genesys International Corporation Ltd: sector, index & market-cap context
Genesys International Corporation Ltd (GENESYS) is a small-cap NSE-listed company, with a market capitalisation of ₹1,521 Cr. See more stocks on our screener.
How the GENESYS Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Genesys International Corporation Ltd's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
GENESYS analysis, FAQs
Is Genesys International Corporation Ltd (GENESYS) a good buy?
On the numbers, Genesys International Corporation Ltd (GENESYS) high-risk on the numbers, a Downstox Snapshot Score of 22/100, weighing expensive at 42.1× earnings, ROE of 5.7%, a 44% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is GENESYS overvalued or undervalued?
GENESYS trades at 42.1× earnings, expensive versus the ~22× long-run Nifty average.
What is the GENESYS share price target for 2031?
GENESYS's probability-weighted 2031 median target is ₹141, with an 80% range of ₹20-₹992 (10,000-path Monte-Carlo).
What is the probability GENESYS doubles in 5 years?
The modelled probability of GENESYS reaching ₹455 (2×) within 5 years is 22%.
What is the bull case for GENESYS?
Genesys International Corporation Ltd is part of the nifty500 universe with live, tracked fundamentals on Downstox.
What are the risks in GENESYS?
GENESYS's P/E of 42.1x is lower than 32% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. GENESYS's return on equity of 5.7% ranks in the 32nd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026. The probability model is cautious 12 months out, only a 44% chance of finishing above today's price.